| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Yasuda S et al. | Oral contraceptives as substrates and inhibitors for human cytosolic SULTs. | 2005 | J. Biochem. | pmid:15809343 |
| Junaidi A et al. | Norethisterone enanthate has neither a direct effect on the testis nor on the epididymis: a study in adult male cynomolgus monkeys (Macaca fascicularis). | 2005 | Eur. J. Endocrinol. | pmid:15817923 |
| Griffith SG and Dai Y | Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. | 2004 | Clin Ther | pmid:15823769 |
| Hofling M et al. | Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density. | 2005 | Gynecol. Endocrinol. | pmid:15823831 |
| pmid:15840751 | ||||
| D'Anna R et al. | The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. | 2005 | Acta Obstet Gynecol Scand | pmid:15842212 |
| pmid:15842506 | ||||
| pmid:15846228 | ||||
| Shirk RA et al. | Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15857755 |
| Honjo H et al. | Progestins and estrogens and Alzheimer's disease. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15860274 |
| Catanzaro LM and Morse GD | Data from clinical trials. | 2005 | J. Acquir. Immune Defic. Syndr. | pmid:15867609 |
| Heard I | Data from the French cohort studies and framing the French contraceptive guidelines. | 2005 | J. Acquir. Immune Defic. Syndr. | pmid:15867610 |
| Menendez JA et al. | The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. | 2005 | Int. J. Oncol. | pmid:15870863 |
| Al-Azzawi F et al. | Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate. | 2005 May-Jun | Menopause | pmid:15879923 |
| Talwar PP et al. | Endometrial control: a comparative study of three oral contraceptives. | 1976 | Int J Gynaecol Obstet | pmid:15901 |
| Vardy MD et al. | The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model. | 2005 | Am. J. Obstet. Gynecol. | pmid:15902188 |
| Edelman DA et al. | An assessment of the side effects of switching from one oral contraceptive to another. | 1976 | Int J Gynaecol Obstet | pmid:15904 |
| Gallmeier E et al. | Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX. | 2005 | Carcinogenesis | pmid:15905198 |
| Murphy PA et al. | Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. | 2005 | Contraception | pmid:15914127 |
| Kim-Björklund T et al. | Is the contraceptive effect of 300 micrograms of norethisterone mainly peripheral or central? | 1992 | Contraception | pmid:1591922 |
| Nahas-Neto J et al. | Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy. | 2006 | Maturitas | pmid:15941630 |
| pmid:15957930 | ||||
| Modena MG et al. | New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. | 2005 | Maturitas | pmid:15963666 |
| pmid:15964400 | ||||
| Taner MZ et al. | Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. | 2006 | Maturitas | pmid:15978753 |
| Suparto IH et al. | A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy. | 2005 | Coron. Artery Dis. | pmid:16000888 |
| Zhou D et al. | [Study of drug displacement interactions by capillary electrophoresis-frontal analysis]. | 2005 | Se Pu | pmid:16013566 |
| Pluchino N et al. | Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. | 2005 | Gynecol. Endocrinol. | pmid:16019353 |
| Heald A et al. | Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. | 2005 | Gynecol. Endocrinol. | pmid:16019358 |
| Franke HR et al. | Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. | 2005 | Gynecol. Endocrinol. | pmid:16019373 |
| Ng LF et al. | Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. | 2005 | PLoS Med. | pmid:16033304 |
| Gallo MF et al. | Combination injectable contraceptives for contraception. | 2005 | Cochrane Database Syst Rev | pmid:16034938 |
| Rolnick SJ et al. | Hormone use and patient concerns after the findings of the Women's Health Initiative. | 2005 Jul-Aug | Menopause | pmid:16037754 |
| Krämer EA et al. | The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. | 2005 Jul-Aug | Menopause | pmid:16037763 |
| Naftolin F and Harman SM | Progesterone abolishes estrogen and/or atorvastatin endothelial dependent vasodilatory effects. | 2005 | Atherosclerosis | pmid:16039298 |
| Lindenmaier H et al. | Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2). | 2005 | Drug Metab. Dispos. | pmid:16049127 |
| Utian WH | Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. | 2005 | Health Qual Life Outcomes | pmid:16083502 |
| OsmanaÄŸaoÄŸlu MA et al. | Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women. | 2005 | Fertil. Steril. | pmid:16084879 |
| Mirkin S et al. | Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. | 2005 | Fertil. Steril. | pmid:16084894 |
| Berger GS et al. | The probability of side effects with ovral, norinyl 1/50 and norlestrin. | 1979 | Contraception | pmid:160860 |
| Buhariwalla HK et al. | Development of ESTs from chickpea roots and their use in diversity analysis of the Cicer genus. | 2005 | BMC Plant Biol. | pmid:16107212 |
| Moss SF et al. | Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone. | 1992 | Gut | pmid:1612493 |
| Koubovec D et al. | Synthetic progestins used in HRT have different glucocorticoid agonist properties. | 2005 | Mol. Cell. Endocrinol. | pmid:16125839 |
| Seeger H et al. | Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells. | 2005 | Horm. Metab. Res. | pmid:16138258 |
| Kwok S et al. | Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. | 2006 | Maturitas | pmid:16139447 |
| Vitale C et al. | Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. | 2005 Sep-Oct | Menopause | pmid:16145309 |
| Rinaldi M et al. | Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis. | 2005 Sep-Oct | Menopause | pmid:16145317 |
| Bray JD et al. | Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:16157482 |
| Héctor FH et al. | Inhibition of the acrosome reaction (AR) and fertilization capacity of mouse spermatozoa by norethisterone A-ring reduced metabolite (5alpha-NET). | 2005 | Andrologia | pmid:16164431 |
| Brown CM et al. | Contraception in teens with medical problems. | 2005 | J Pediatr Adolesc Gynecol | pmid:16171736 |